Work

Novel YAP inhibitor, CA3, demonstrates antitumoral activity in vitro and in vivo model of cholangiocarcinoma

Year: 2021

Type: article

Source: HPB

DOI: 10.1016/j.hpb.2021.06.112

Authors: R. Alva-Ruiz, J. Yonkus, R. Watkins, A. Abdelrahman, C. Conboy, M. Truty, R. Smoot

Language: English

Topic: Hippo pathway signaling and YAP/TAZ

Subfield: Cell Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3200753670

FWCI:

Cites:

Cited by: 1

Related to: 10